Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

SHE:002873 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	99.76	118.16	138.24	100.67	72.48	330.09
Trading Asset Securities	0.11	0.12	0.09	0.11	80	118
Cash & Short-Term Investments	99.86	118.28	138.33	100.78	152.48	448.09
Cash Growth	-29.03%	-14.49%	37.26%	-33.91%	-65.97%	146.67%
Accounts Receivable	328.71	325.67	250.54	261.96	282.72	249.96
Other Receivables	18.93	18.7	48.22	42.12	21.52	18.16
Receivables	347.64	344.37	298.76	304.08	304.24	268.13
Inventory	129.52	145.48	184.33	183.34	118.77	86.82
Other Current Assets	11.79	8.68	15	22.44	11.34	9.85
Total Current Assets	588.81	616.81	636.43	610.65	586.83	812.88
Property, Plant & Equipment	704.49	708.83	706.3	593.75	463.94	381.09
Long-Term Investments	412.07	412.07	383.27	461.57	312.5	183.64
Other Intangible Assets	107.42	108.96	83.52	86.1	87.51	79.51
Long-Term Deferred Tax Assets	10.29	10.06	10.33	13.46	11.26	12.6
Long-Term Deferred Charges	91.03	90.36	88.45	70.39	58.67	62.39
Other Long-Term Assets	3.39	3.41	3.5	3.6	3.71	3.81
Total Assets	1,917	1,951	1,912	1,840	1,524	1,536
Accounts Payable	65.16	83.36	105.08	95.67	64.89	44.81
Accrued Expenses	13.71	15.28	31.8	39.71	53.85	43.38
Short-Term Debt	121.13	306.24	366.93	317.37	268.34	402.02
Current Portion of Long-Term Debt	32.36	25.77	26.03	5.01	-	2.46
Current Portion of Leases	-	-	4.16	1.4	-	-
Current Income Taxes Payable	21.48	19.34	0	2.29	4.72	3.71
Current Unearned Revenue	0.55	0.52	1	13.86	15.36	7.9
Other Current Liabilities	18.52	30.85	20.42	26.4	34.07	9.36
Total Current Liabilities	272.92	481.38	555.42	501.69	441.23	513.64
Long-Term Debt	391.88	221.4	195.54	156.68	154.79	159.95
Long-Term Leases	7.75	6.77	9.35	5.72	6.65	-
Long-Term Unearned Revenue	23.44	23.58	20.83	22.15	24.51	24
Long-Term Deferred Tax Liabilities	22.06	22.11	16.72	27.99	3.38	6.55
Other Long-Term Liabilities	0.53	0.55	0.59	3.36	3.42	3.5
Total Liabilities	718.59	755.79	798.47	717.59	633.98	707.64
Common Stock	244.1	244.1	231.49	231.97	164.05	117.15
Additional Paid-In Capital	282.35	282.35	179.72	187	220.67	281.76
Retained Earnings	669.51	665.32	637.57	579.88	490.94	404.35
Treasury Stock	-75.3	-75.3	-9.54	-17.61	-27.81	-35.6
Comprehensive Income & Other	78.24	78.24	74.09	140.69	42.61	60.63
Total Common Equity	1,199	1,195	1,113	1,122	890.44	828.3
Shareholders' Equity	1,199	1,195	1,113	1,122	890.44	828.3
Total Liabilities & Equity	1,917	1,951	1,912	1,840	1,524	1,536
Total Debt	553.13	560.18	602.01	486.17	429.79	564.43
Net Cash (Debt)	-453.26	-441.9	-463.68	-385.39	-277.31	-116.35
Net Cash Per Share	-2.03	-2.01	-1.90	-1.58	-1.13	-0.48
Filing Date Shares Outstanding	243.46	189.36	231.4	231.89	228.31	225.3
Total Common Shares Outstanding	243.46	189.36	231.4	231.89	228.31	225.3
Working Capital	315.89	135.43	81	108.96	145.59	299.24
Book Value Per Share	4.92	6.31	4.81	4.84	3.90	3.68
Tangible Book Value	1,091	1,086	1,030	1,036	802.93	748.78
Tangible Book Value Per Share	4.48	5.73	4.45	4.47	3.52	3.32
Buildings	-	-	643.46	369.03	327.11	293.66
Machinery	-	-	163.46	121.47	92.52	84.84
Construction In Progress	-	-	33.72	228.36	151.22	99.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.